Cargando…

Rational for Drug Dosimetry and Duration of Terbinafine in the Context of Recalcitrant Dermatophytosis: Is 500 mg Better than 250 mg OD or BD?

Detalles Bibliográficos
Autores principales:	Sardana, Kabir, Gupta, Aastha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Correspondences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724319/ https://www.ncbi.nlm.nih.gov/pubmed/29263545 http://dx.doi.org/10.4103/ijd.IJD_435_17

Ejemplares similares

Efficacy and Safety of Terbinafine 500 mg Once Daily in Patients with Dermatophytosis
por: Babu, P Ravindra, et al.
Publicado: (2017)

Final Overall Survival: Fulvestrant 500mg vs 250mg in the Randomized CONFIRM Trial
por: Leo, Angelo Di, et al.
Publicado: (2013)

Comparison between the efficacy of terbinafine and itraconazole orally vs. the combination of the two drugs in treating recalcitrant dermatophytosis
por: Hassaan, Zinab Rabia Abo Almaati, et al.
Publicado: (2023)

Super Bioavailable Itraconazole and Its Place and Relevance in Recalcitrant Dermatophytosis: Revisiting Skin Levels of Itraconazole and Minimum Inhibitory Concentration Data
por: Sardana, Kabir, et al.
Publicado: (2021)

Immunopathogenesis of Dermatophytoses and Factors Leading to Recalcitrant Infections
por: Sardana, Kabir, et al.
Publicado: (2021)

Extensive Dermatophytosis Caused by Terbinafine-Resistant Trichophyton indotineae, France
por: Jabet, Arnaud, et al.
Publicado: (2022)

Development and Characterization of Terbinafine-Loaded Nanoemulgel for Effective Management of Dermatophytosis
por: Phagna, Mayank, et al.
Publicado: (2023)

Fulvestrant 500 mg vs 250 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer: a randomized, double-blind registrational trial in China
por: Zhang, Qingyuan, et al.
Publicado: (2016)

Relapse after Oral Terbinafine Therapy in Dermatophytosis: A Clinical and Mycological Study
por: Majid, Imran, et al.
Publicado: (2016)

A comparison of two doses of tamoxifen (Nolvadex) in postmenopausal women with advanced breast cancer: 10 mg bd versus 20 mg bd.
por: Bratherton, D. G., et al.
Publicado: (1984)

Methotrexate Cutaneous Toxicity following a Single Dose of 10 mg in a Case of Chronic Plaque Psoriasis: A Possible Idiosyncratic Reaction
por: Gupta, Aastha, et al.
Publicado: (2018)

Oral Isotretinoin Combined with Oral Terbinafine Versus Oral Terbinafine Alone to Treat Recurrent Dermatophytosis: An Open-Label Randomised Clinical Trial
por: Verma, Kaushal K., et al.
Publicado: (2021)

Looking Beyond the Cyclosporine “Swish and Spit” Technique in a Recalcitrant Case of Erosive Lichen Planus Involving the Tongue
por: Gupta, Aastha, et al.
Publicado: (2017)

Effect of fluconazole and terbinafine nanoparticles on the treatment of dermatophytosis induced by Trichophyton mentagrophytes in guinea pig
por: Lalvand, Mahshid, et al.
Publicado: (2021)

Brand versus generic dispensing trend for ciprofloxacin 500 mg, levofloxacin 500 mg, and moxifloxacin 400 mg (oral dosage forms) among pharmacies of Karachi, Pakistan
por: Zehra, Fatima, et al.
Publicado: (2017)

1490. Vancomycin 125 mg vs. 250 mg for the Treatment of Non-Severe and Severe Clostridium difficile Infections
por: Hsu, Amy, et al.
Publicado: (2019)

Cyclophosphamide in a Recalcitrant Case of Nekam’s Disease
por: Muddebihal, Aishwarya, et al.
Publicado: (2023)

Pharmacokinetic properties and bioequivalence of gefitinib 250 mg in healthy Korean male subjects
por: Moon, Seol Ju, et al.
Publicado: (2021)

Pharmacokinetics, Safety, and Tolerability of a Single 500-mg or 1000-mg Intravenous Dose of Dalbavancin in Healthy Japanese Subjects
por: Scoble, Patrick J., et al.
Publicado: (2015)

Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial
por: Cooper, David A., et al.
Publicado: (2016)

Terbinafine Induced Acute Generalized Exanthematous Pustulosis Treated with Adalimumab: Recalcitrant to Systemic Corticosteroid Therapy
por: Deng, Lin, et al.
Publicado: (2023)

Interchangeability of Two 500 Mg Amoxicillin Capsules with One 1000 Mg Amoxicillin Tablet After a Single Oral Administration
por: Zaid, A. N., et al.
Publicado: (2010)

Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India)
por: Rajagopalan, Murlidhar, et al.
Publicado: (2018)

Efficacy and tolerability of topical sertaconazole versus topical terbinafine in localized dermatophytosis: A randomized, observer-blind, parallel group study
por: Chatterjee, Dattatreyo, et al.
Publicado: (2016)

Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment-experienced patients (pts) with HIV RNA <50 copies/mL
por: Casado, JL, et al.
Publicado: (2010)

Antifungal Efficacy of Amphotericin B against Dermatophytes and its Relevance in Recalcitrant Dermatophytoses: A Commentary
por: Sinha, Surabhi, et al.
Publicado: (2018)

Should the dose of tenofovir be reduced to 200–250 mg/day, when combined with protease inhibitors?
por: Hill, Andrew, et al.
Publicado: (2014)

A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer
por: Robertson, John FR, et al.
Publicado: (2013)

Histopathology of Hair Follicle Epithelium in Patients of Recurrent and Recalcitrant Dermatophytosis: A Diagnostic Cross-Sectional Study
por: Patil, Payal Dilip, et al.
Publicado: (2019)

Efficacy and Tolerability of Erlotinib 100 mg/d vs. Gefitinib 250 mg/d in EGFR-Mutated Advanced Non-small Cell Lung Cancer (E100VG250): An Open-Label, Randomized, Phase 2 Study
por: Zhao, Shen, et al.
Publicado: (2020)

Quality assessment of nine paracetamol 500 mg tablet brands marketed in Saudi Arabia
por: AlSwayeh, Reem, et al.
Publicado: (2021)

1125. Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalized adults with severe COVID-19 pneumonia: an open-label randomized trial.
por: Gutierrez, Carlos Dueñas, et al.
Publicado: (2022)

Analgesic effect of oral ibuprofen 400, 600, and 800 mg; paracetamol 500 and 1000 mg; and paracetamol 1000 mg plus 60 mg codeine in acute postoperative pain: a single-dose, randomized, placebo-controlled, and double-blind study
por: Lyngstad, Gaute, et al.
Publicado: (2021)

Monopolar 250–500 Hz language mapping: Results of 41 patients
por: Verst, S.M., et al.
Publicado: (2018)

Is Antifungal Resistance a Cause for Treatment Failure in Dermatophytosis: A Study Focused on Tinea Corporis and Cruris from a Tertiary Centre?
por: Sardana, Kabir, et al.
Publicado: (2018)

A Clinical-Mycological Study of Dermatophytosis in Western India with Focus on Antifungal Drug Resistance as a Factor in Recalcitrance
por: Shah, Shikha R., et al.
Publicado: (2023)

Disinfection trials with terbinafine‐susceptible and terbinafine‐resistant dermatophytes
por: Skaastrup, Kristoffer Nagy, et al.
Publicado: (2022)

Rituximab 500 mg 6-monthly infusions is an option in maintenance therapy of ANCA-associated vasculitis
por: Goel, Ruchika, et al.
Publicado: (2021)

Evaluation of the safety of 500 mg intravenous push thiamine at a tertiary academic medical center
por: Aldhaeefi, Mohammed, et al.
Publicado: (2022)

The Daily Therapy With L-Arginine 2,500 mg and Tadalafil 5 mg in Combination and in Monotherapy for the Treatment of Erectile Dysfunction: A Prospective, Randomized Multicentre Study
por: Gallo, Luigi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0a7j1an6ft8sbup5a02ts905g4